Search
for

    Sort by

    Research 181–210 of 1000+

    1. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata Drug Design Development and Therapy · 2022 · 49 citations
    2. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 18 citations
    3. Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus Lupus · 2016 · 14 citations
    4. Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older Actas Dermo-Sifiliográficas · 2025
    5. Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients International Journal of Pharmaceutics · 2025
    6. Ichthyosis linearis circumflexa in a child. Response to narrowband UVB therapy. Journal of Dermatological Case Reports · 2015 · 9 citations
    7. Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib Actas Dermo-Sifiliográficas · 2023 · 2 citations
    8. Activated Platelet Rich Plasma versus Non-Activated Platelet Rich Plasma in the Treatment of Alopecia Areata Skin appendage disorders · 2022 · 2 citations
    9. Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib Journal of Inflammation Research · 2025
    10. Autoinmune Alopecia/Alopecia Areata 2024
    11. A phase 2a trial of brepocitinib for cicatricial alopecia Journal of the American Academy of Dermatology · 2024 · 17 citations
    12. A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation Indian Dermatology Online Journal · 2024 · 2 citations
    13. Immune Privilege Collapse and Alopecia Development: Is Stress a Factor Skin Appendage Disorders · 2017 · 51 citations
    14. The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris Frontiers in Immunology · 2022 · 49 citations
    15. Deciphering the Complex Immunopathogenesis of Alopecia Areata International Journal of Molecular Sciences · 2024 · 45 citations
    16. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response. PubMed · 1975 · 31 citations
    17. Research progress on the natural products in the intervention of myocardial infarction Frontiers in Pharmacology · 2024 · 9 citations
    18. Hydrogels Modulating the Microbiome: Therapies for Tissue Regeneration with Infection Control Gels · 2025 · 8 citations
    19. Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives Discover Immunity. · 2025 · 2 citations
    20. Exploring differential gene expression and biomarker potential in systemic lupus erythematosus: a retrospective study PeerJ · 2025
    21. Revitalizing Effect on the Scalp After Injection with a Mechanically Stabilized Hyaluronic Acid Complex in Subjects with Androgenetic Alopecia Journal of Clinical Medicine · 2024
    22. Cicatricial Alopecias InTech eBooks · 2017
    23. Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway PLOS ONE · 2016 · 10 citations
    24. A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results Journal of the American Academy of Dermatology · 2021 · 138 citations
    25. Management of tinea capitis in childhood Clinical, cosmetic and investigational dermatology · 2010 · 38 citations
    26. Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream Pharmaceutics · 2021 · 24 citations
    27. Efficacy and Tolerability of a Shampoo Containing Broad-Spectrum Cannabidiol in the Treatment of Scalp Inflammation in Patients with Mild to Moderate Scalp Psoriasis or Seborrheic Dermatitis Skin appendage disorders · 2020 · 14 citations
    28. Post-partum pituitary insufficiency and livedo reticularis presenting a diagnostic challenge in a resource limited setting in Tanzania: a case report, clinical discussion and brief review of existing literature BMC Endocrine Disorders · 2012 · 3 citations
    29. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024 · 63 citations
    30. Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring International Journal of Dermatology · 2017 · 25 citations